Navigation Links
TCT 2010 late breaking trials to have impact on practice of interventional cardiology
Date:9/7/2010

patients with severe aortic stenosis.

  • Drug-Eluting Stents and Diabetes: SPIRIT IV is the largest randomized trial to date comparing two drug-eluting stents. The two-year outcomes from this trial will provide important insights into the absolute and relative long-term safety and efficacy outcomes of everolimus-eluting and paclitaxel-eluting stents in a complex patient population, including 1,185 randomized patients with diabetes.

  • Drug-Eluting Stents: The COMPARE trial compares the outcomes of the everolimus-eluting stent versus the paclitaxel-eluting stent in an all-comer population after 2 years.

  • Pharmaceutical Therapy: The LANCELOT ACS study evaluates the safety and efficacy of a reversible PAR-1 thrombin receptor antagonist in patients with Acute Coronary Syndrome.

  • Drug-Coated Catheter: The LEVANT 1 trial assesses the safety and efficacy of a novel drug-coated angioplasty balloon catheter for the treatment of femoropopliteal disease after 6 months.

  • Drug-Eluting Catheter: The PERfECT STENT study evaluates whether treatment with a drug-eluting stent and a paclitaxel-eluting balloon catheter is superior to treatment with the drug-eluting stent alone.

    FRIDAY, SEPTEMBER 24

    • Stenting in the Femoral Artery: The ZILVER PTX trial examines the first drug-eluting stent approved (currently CE marked, investigational in the U.S.) for the superficial femoral artery (SFA). This study compares the safety and effectiveness of the Zilver PTX drug-eluting peripheral stent to balloon angioplasty (PTA) and bare-metal stenting (BMS) after 12 months.

    • Drug-Eluting Stents: The SORT OUT-4 trial compares the safety and efficacy of the sirolimus-eluting stent, which has demonstrated the least amount of late lumen loss among previously released drug-eluting stents, with a next-generation everolimus-eluting stent in patients with coronary artery disease after 9 months.

    • Drug
      '/>"/>

    Contact: Judy Romero
    jromero@crf.org
    Cardiovascular Research Foundation
    Source:Eurekalert

    Page: 1 2 3 4

    Related medicine news :

    1. CRF announces late breaking trials and first report investigations to be presented at TCT 2010
    2. The Institute for Health Metrics and Evaluation selects DatStat as the foundation for ground breaking healthcare project
    3. Enterprise Architecture -- Breaking Away From The Pack
    4. American Association for Cancer Research has Record-breaking Registration at 101st Annual Meeting
    5. Ground-breaking study to improve quality of life and outcomes for kids born with heart defect
    6. World Record-Breaking CPR and AED Training Event at the 2010 National Scout Jamboree
    7. Breaking down barriers in brain imaging
    8. Second volume of groundbreaking Emerging Model Organisms series is released
    9. Groundbreaking MS research to be presented at American Academy of Neurology Annual Meeting
    10. LASIK Surgeons, Plastic Surgeons, Cosmetic Dentists and other Cash Paid Medical Specialists Brought Together for Groundbreaking Webinar Series
    11. Business Book Author is Breaking All the Rules and Utilizing Social Media in a Way that Has Never Been Done Before
  • Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/31/2015)... ... July 31, 2015 , ... Eldermark ... for LeadingAge’s Center for Aging Services Technologies (CAST) Medication Management Technologies whitepaper. The ... post-acute care providers understand the benefits of using medication management technologies . ...
    (Date:7/31/2015)... ... July 31, 2015 , ... ... Hospital's Karmanos Center for Natural Birth . The Karmanos Center for ... safe natural childbirth experience. With nurses and caregivers that are trained in holistic ...
    (Date:7/31/2015)... ... July 31, 2015 , ... New Energy Works Timberframers ... Amphitheater in McMinnville, Oregon August 15th, 2015 from 9am – 12pm. Timber frame ... important day for the entire community as the culmination of months of effort, planning, ...
    (Date:7/31/2015)... ... July 31, 2015 , ... An article entitled ... talked about a woman’s unfortunate experience having cosmetic skin procedures done by a ... resulted in blistering, swelling, bruising, and pain. This woman’s experience is only one ...
    (Date:7/31/2015)... ... July 31, 2015 , ... In the most recent testosterone ... in the Northern District of Illinois, Androgel testosterone attorneys report that a “Mini Status ... entry was made recording the minutes of the status conference, which was held that ...
    Breaking Medicine News(10 mins):Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 2Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 3Health News:Timber Frame Raising: Granary District Stage Amphitheater Timber Frame Hand-Raising by New Energy Works Timberframers 2Health News:Timber Frame Raising: Granary District Stage Amphitheater Timber Frame Hand-Raising by New Energy Works Timberframers 3Health News:Dermatologists Discuss Rise in Unqualified Practitioners of Cosmetic Dermatology 2Health News:Dermatologists Discuss Rise in Unqualified Practitioners of Cosmetic Dermatology 3Health News:Testosterone Lawsuit News: Androgel Lawsuit Conference Held 2Health News:Testosterone Lawsuit News: Androgel Lawsuit Conference Held 3Health News:Testosterone Lawsuit News: Androgel Lawsuit Conference Held 4
    ... Joins Thousands of Participants in Inspirational Closing Ceremony; ... Breast Cancer Organizations, WASHINGTON, May 4 ... Reese Witherspoon was a special guest at the,sixth ... this weekend,cheering on and joining walkers on their ...
    ... to an expanding waist line, weight gain and a tendency ... of a study published today in the journal Nature Genetics. ... is significantly more common in those with Indian Asian than ... Heart Foundation, could lead to better ways of treating obesity. ...
    ... knowledge gap, experts say , , SUNDAY, May 4 (HealthDay ... surprisingly low knowledge of child development, including basic concepts ... should act, a new study finds. , For instance, ... 1-year-olds can,t tell the difference between right and wrong, ...
    ... Study shows only 49% intended to do so if child ... News) -- New research shows that only half of American ... papillomavirus (HPV) if the girls are under the age of ... which is sexually transmitted, is the primary cause of cervical ...
    ... assumptions, children are more vulnerable to the harmful effects ... they are in early childhood, according to a Cincinnati ... 4 at the annual meeting of the Pediatric Academic ... protecting toddlers from lead exposure, our study shows that ...
    ... U.S. parents have a surprisingly low-level knowledge of ... childs physical, social and emotional growth, according research ... which suggest that such false parenting assumptions can ... kids of much-needed cognitive stimulation, will be presented ...
    Cached Medicine News:Health News:Reese Witherspoon Helps Celebrate Avon Walk for Breast Cancer Washington, D.C. - Weekend-Long Event Raises $8.1 Million 2Health News:Reese Witherspoon Helps Celebrate Avon Walk for Breast Cancer Washington, D.C. - Weekend-Long Event Raises $8.1 Million 3Health News:Reese Witherspoon Helps Celebrate Avon Walk for Breast Cancer Washington, D.C. - Weekend-Long Event Raises $8.1 Million 4Health News:Reese Witherspoon Helps Celebrate Avon Walk for Breast Cancer Washington, D.C. - Weekend-Long Event Raises $8.1 Million 5Health News:Reese Witherspoon Helps Celebrate Avon Walk for Breast Cancer Washington, D.C. - Weekend-Long Event Raises $8.1 Million 6Health News:Gene sequence that can make half of us fatter is discovered 2Health News:One-Third of Parents Lack Facts About Child Development 2Health News:One-Third of Parents Lack Facts About Child Development 3Health News:Many Moms Unwilling to Have Younger Daughters Get HPV Vaccine 2Health News:Many Moms Unwilling to Have Younger Daughters Get HPV Vaccine 3Health News:Children more vulnerable to harmful effects of lead 2Health News:Nearly one-third of US parents don't know what to expect of infants 2
    (Date:7/31/2015)... 31, 2015 Magnaquest, a ... data and cloud computing operators has signed a ... giant for Internet of Things (IoT) related initiative. ... on subscription model.      (Logo: ... striving for business innovations to make healthcare services ...
    (Date:7/30/2015)... VIEW, Calif. , July 30, 2015 ... it will release its second quarter 2015 financial results ... 2015.   In conjunction with the release, the Company ... at 5:00 p.m. Eastern Time on ... of the quarter and other business developments. ...
    (Date:7/30/2015)... edition of #MedicareMonday on Medicare,s 50 th anniversary. As Medicare celebrates 50 years, ... the success of the prescription drug benefit, commonly referred to as Part D. ... videos here: http://onphr.ma/1INp9qQ ... ... More ...
    Breaking Medicine Technology:Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2IRIDEX Announces Second Quarter 2015 Conference Call and Release Date 2Happy 50th Anniversary Medicare! 2Happy 50th Anniversary Medicare! 3
    ... in Combination with Chemotherapy, FREMONT, Calif. ... pharmaceutical company discovering and developing novel,RNA interference ... Research published results on efficacy of siRNA ... lung cancer (NSCLC) in,the edition dated October ...
    ... Pivotal Data Show Prophylaxis Treatment with Kogenate FS ... in Children with No Pre-Existing,Joint Damage, BERKELEY, ... that the U.S. Food and Drug Administration (FDA) ... to reduce the frequency of bleeding episodes and ...
    Cached Medicine Technology:Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 2Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 3Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 4FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 2FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 3FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 4FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 5
    Khosla Precision and Quality in Medical and Surgical Products....
    Khosla Precision and Quality in Medical and Surgical Products....
    Khosla Precision and Quality in Medical and Surgical Products....
    Manual Table For Slit Lamp...
    Medicine Products: